Edition:
India

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.77USD
18 Oct 2019
Change (% chg)

$0.01 (+0.94%)
Prev Close
$0.76
Open
$0.79
Day's High
$0.79
Day's Low
$0.74
Volume
43,902
Avg. Vol
73,077
52-wk High
$3.71
52-wk Low
$0.66

Latest Key Developments (Source: Significant Developments)

Biocept Says Got Letter From Nasdaq Indicating Co Has Failed To Comply With Minimum Bid Price Requirement
Saturday, 28 Sep 2019 

Sept 27 (Reuters) - Biocept Inc ::BIOCEPT - ON SEPTEMBER 26, GOT LETTER FROM NASDAQ INDICATING CO HAS FAILED TO COMPLY WITH MINIMUM BID PRICE REQUIREMENT.BIOCEPT - MONITORING BID PRICE OF COMMON STOCK, WILL CONSIDER OPTIONS AVAILABLE TO POTENTIALLY ACHIEVE COMPLIANCE.  Full Article

Biocept Announces Laboratory Services Provider Agreement With Beaconlbs
Monday, 22 Jul 2019 

July 22 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES LABORATORY SERVICES PROVIDER AGREEMENT WITH BEACONLBS®.BIOCEPT INC - BEACONLBS NOW OFFERS BIOCEPT'S TARGET SELECTOR™ TESTING FOR LIQUID BIOPSY AS PART OF ITS LABORATORY MANAGEMENT NETWORK IN UNITED STATES.  Full Article

Biocept Q1 Loss Per Share $0.61
Thursday, 9 May 2019 

May 8 (Reuters) - Biocept Inc ::BIOCEPT REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.61.Q1 REVENUE $1.0 MILLION.QTRLY REVENUES INCREASED 27% COMPARED TO Q1 OF 2018.NET LOSS FOR Q1 OF 2019 WAS $5.9 MILLION, OR $0.61 PER SHARE.  Full Article

Biocept Inc Files For Offering Of Up To 5.95 Mln Shares Of Co's Common Stock By The Selling Stockholders
Thursday, 11 Apr 2019 

April 10 (Reuters) - Biocept Inc ::BIOCEPT INC FILES FOR OFFERING OF UP TO 5.95 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING.  Full Article

Biocept Q4 Loss Per Share $1.43
Friday, 29 Mar 2019 

March 28 (Reuters) - Biocept Inc ::BIOCEPT REPORTS 2018 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS.Q4 LOSS PER SHARE $1.43.Q4 EARNINGS PER SHARE ESTIMATE $-1.41 -- REFINITIV IBES DATA.Q4 REVENUE $860,000 VERSUS REFINITIV IBES ESTIMATE OF $912,000.CASH AND CASH EQUIVALENTS WERE $3.4 MILLION AS OF DECEMBER 31, 2018, COMPARED WITH $2.1 MILLION AS OF DECEMBER 31, 2017.  Full Article

Biocept Announces Pricing Of $7.5 Mln Underwritten Public Offering
Friday, 8 Feb 2019 

Feb 8 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF $7.5 MILLION UNDERWRITTEN PUBLIC OFFERING.BIOCEPT - EACH SHARE OF IS BEING SOLD TOGETHER WITH ONE WARRANT TO PURCHASE ONE SHARE AT A COMBINED PRICE TO PUBLIC OF $1.20 PER SHARE AND WARRANT.BIOCEPT INC - WARRANTS WILL BE IMMEDIATELY EXERCISABLE AT A PRICE OF $1.20 PER SHARE OF COMMON STOCK AND WILL EXPIRE FIVE YEARS FROM DATE OF ISSUANCE.  Full Article

Lincoln Park Capital Fund Llc Reports 9.99 Pct Passive Stake In Biocept Inc As Of September 20
Tuesday, 25 Sep 2018 

Sept 24 (Reuters) - Biocept Inc ::LINCOLN PARK CAPITAL FUND LLC REPORTS 9.99 PERCENT PASSIVE STAKE IN BIOCEPT INC AS OF SEPTEMBER 20 - SEC FILING.  Full Article

Biocept Enters Into Agreement With Alliance Global FZ
Friday, 13 Jul 2018 

July 13 (Reuters) - Biocept Inc ::BIOCEPT ENTERS INTO AGREEMENT WITH ALLIANCE GLOBAL FZ TO MARKET AND DISTRIBUTE LIQUID BIOPSY TESTING IN THE MIDDLE EAST, SOUTHEAST ASIA, AND AFRICA REGION.BIOCEPT INC - ADDITIONAL TERMS OF AGREEMENT WERE NOT DISCLOSED..BIOCEPT - EXPANDS INTERNATIONAL DISTRIBUTION OF TARGET SELECTOR PLATFORM TO 17 COUNTRIES.  Full Article

Biocept Says Pursuant To Approval Of Co's Board, Co Effected A Reverse Stock Split Of Co's Common Stock
Saturday, 7 Jul 2018 

July 6 (Reuters) - Biocept Inc ::BIOCEPT SAYS PURSUANT TO APPROVAL OF CO'S BOARD, CO EFFECTED A REVERSE STOCK SPLIT OF CO'S COMMON STOCK AT A RATIO OF 1:30 - SEC FILING.  Full Article

Biocept Inc Files For Mixed Shelf Of Up To $50 Million
Wednesday, 16 May 2018 

May 15 (Reuters) - Biocept Inc ::BIOCEPT INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING.  Full Article